USC IBT converges both medicine and engineering to create neural interfaces to develop treatments for patients with degenerative neurological conditions.
USC Dr. Allen and Charlotte Ginsburg IBT naming ceremony! LR-Dean Mosqueda, Dr. Allen and Charlotte Ginsburg, Dr. Humayun and Interim President Wanda Austin! @USCIBT@USCeye @KeckMedUSC @USCviterbi@USCDornsife @USCSchpharmacy
Retired ophthalmologist Allen Ginsburg and his wife, Charlotte, donate $10 million to name the USC Institute for Biomedical Therapeutics. @USCEye
https://t.co/27eYDjvOlT
#USCIBT and #USCeye investigators report encouraging results from first-in-kind stem cell-based clinical trial for dry AMD. https://t.co/27eYDjvOlT
Featured as cover story #ScienceTM#CIRM
#USCIBT and #USCeye Investigators report encouraging results from first-in-kind stem cell-based clinical trial published as cover story @ScienceTM https://t.co/o22FtFjv9N
Director of #USCIBT and co-Director of #USCEye, Mark Humayun, MD, PhD, elected as a fellow of the 2016 National Academy of Inventors https://t.co/L0ZyC8JJHY